Headlines

SAN DIEGO, April 18, 2010–AltheaDx, Inc., a leader in the development of companion diagnostics, and The Nicholas Conor Institute for Pediatric Cancer Research, announced today that they have entered into collaboration to:
+

San Diego, CA, March 10, 2010 – AltheaDx, Inc., a privately held molecular diagnostics company and a leader in the development of companion diagnostics for biopharmaceutical partners, announced that it has completed a $6 million Series A equity and growth financing.
+

SAN DIEGO — May 21, 2009 — AltheaDx, a world leader in the development of companion diagnostics and biopharma services, today announced that they have successfully passed the State of California survey for CLIA (Clinical Laboratory Improvement Amendments) certification. AltheaDx is offering high-quality patient and biopharma molecular testing services from their state-of-the-art, GMP, GLP, and now CLIA compliant facility located in the Sorrento Valley, San Diego.
+

SAN DIEGO — May 19, 2009 — AltheaDx, a world leader in the development of companion diagnostics and biopharma services, today announced the appointment of Dr. Eric Topol to their Scientific Advisory Board. Eric J. Topol, M.D. is the Director of the Scripps Translational Science Institute, a National Institutes of Health funded program of the Clinical and Translational Science Award (CTSA) Consortium.
He is Professor of Translational Genomics at The Scripps Research Institute, the Chief Academic Officer of Scripps Health, and a Senior Consultant cardiologist practitioner at Scripps Clinic. In 2009, he became the Gary and Mary West Chair of Innovative Medicine and co-founded the West Wireless Health Institute.
+